Ultragenyx Pharmaceutical Inc.

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ultragenyx Pharmaceutical Inc.'s trades of Arcturus Therapeutics Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-10 2020-12-09
S Sale
26,376 +13.2%
223.92
US$2,772,597 		26,376 +13.2% 223.92 US$2,772,597
2020-12-10 2020-12-08
S Sale
6,153 +35.1%
175.49
US$1,655,080 		6,153 +35.1% 175.49 US$1,655,080